Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 69, Issue 7, 2014, Pages 943-953

  Boos, A C ^a,b   Hagl, B ^a   Schlesinger, A ^a,b   Halm, B E ^a   Ballenberger, N ^a   Pinarci, M ^b   Heinz, V ^a   Kreilinger, D ^a   Spielberger, B D ^a   Schimke Marques, L F ^a   Sawalle Belohradsky, J ^a   Belohradsky, B H ^a   Przybilla, B ^b   Schaub, B ^a   Wollenberg, A ^b   Renner, E D ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

atopic dermatitis; DOCK8 deficiency; hyper IgE syndromes; IgE based sensitization pattern; STAT3 hyper IgE syndrome

Indexed keywords

DOCK8 PROTEIN; FOOD ALLERGEN; IMMUNOGLOBULIN E; PROTEIN; STAT3 PROTEIN; UNCLASSIFIED DRUG; DOCK8 PROTEIN, HUMAN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; STAT3 PROTEIN, HUMAN;

ADULT; ALLERGIC DISEASE; ARTICLE; ASTHMA; ATOPIC DERMATITIS; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; ECZEMA; EOSINOPHILIA; FEMALE; FOOD ALLERGY; HELPER CELL; HUMAN; HYPER IGE SYNDROME; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOREGULATION; LYMPHOCYTE COUNT; MALE; PRICK TEST; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SENSITIZATION; SKIN TEST; T LYMPHOCYTE SUBPOPULATION; TH17 CELL; BLOOD; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; MIDDLE AGED; NUCLEOTIDE SEQUENCE; YOUNG ADULT;

ADULT; DERMATITIS, ATOPIC; DNA MUTATIONAL ANALYSIS; FEMALE; FLOW CYTOMETRY; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; IMMUNOGLOBULIN E; JOB SYNDROME; MALE; MIDDLE AGED; SKIN TESTS; STAT3 TRANSCRIPTION FACTOR; T-LYMPHOCYTES, HELPER-INDUCER; YOUNG ADULT;

EID: 84901988362     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12416     Document Type: Article

References (44)

1. Bieber T,. Atopic dermatitis 2.0: from the clinical phenotype to the molecular taxonomy and stratified medicine. Allergy 2012; 67: 1475-1482.
2. Bieber T,. Many ways lead to Rome: a glance at the multiple immunological pathways underlying atopic dermatitis. Allergy 2013; 68: 957-958.
3. Bieber T,. Atopic dermatitis. N Engl J Med 2008; 358: 1483-1494.
4. Wollenberg A, Rawer HC, Schauber J,. Innate immunity in atopic dermatitis. Clin Rev Allergy Immunol 2011; 41: 272-281.
5. Eyerich K, Novak N,. Immunology of atopic eczema: overcoming the Th1/Th2 paradigm. Allergy 2013; 68: 974-982.
6. Yong PF, Freeman AF, Engelhardt KR, Holland S, Puck JM, Grimbacher B,. An update on the hyper-IgE syndromes. Arthritis Res Ther 2012; 14: 228.
7. Grimbacher B, Holland SM, Gallin JI, Greenberg F, Hill SC, Malech HL, et al. Hyper-IgE syndrome with recurrent infections-an autosomal dominant multisystem disorder. N Engl J Med 1999; 340: 692-702. (Pubitemid 29110753)
8. Schimke LF, Sawalle-Belohradsky J, Roesler J, Wollenberg A, Rack A, Borte M, et al. Diagnostic approach to the hyper-IgE syndromes: immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitis. J Allergy Clin Immunol 2010; 126: 611-617.
9. Su HC, Jing H, Zhang Q,. DOCK8 deficiency. Ann N Y Acad Sci 2011; 1246: 26-33.
10. Zhang Q, Davis JC, Dove CG, Su HC,. Genetic, clinical, and laboratory markers for DOCK8 immunodeficiency syndrome. Dis Markers 2010; 29: 131-139.
11. Zhang Q, Davis JC, Lamborn IT, Freeman AF, Jing H, Favreau AJ, et al. Combined immunodeficiency associated with DOCK8 mutations. N Engl J Med 2009; 361: 2046-2055.
12. Engelhardt KR, McGhee S, Winkler S, Sassi A, Woellner C, Lopez-Herrera G, et al. Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. J Allergy Clin Immunol 2009; 124: 1289-1302.
13. Renner ED, Puck JM, Holland SM, Schmitt M, Weiss M, Frosch M, et al. Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity. J Pediatr 2004; 144: 93-99. (Pubitemid 38091428)
14. Oboki K, Ohno T, Saito H, Nakae S,. Th17 and allergy. Allergol Int 2008; 57: 121-134. (Pubitemid 351897666)
15. Louten J, Boniface K, de Waal Malefyt R,. Development and function of TH17 cells in health and disease. J Allergy Clin Immunol 2009; 123: 1004-1011.
16. Koga C, Kabashima K, Shiraishi N, Kobayashi M, Tokura Y,. Possible pathogenic role of Th17 cells for atopic dermatitis. J Invest Dermatol 2008; 128: 2625-2630.
17. Beissert S, Schwarz A, Schwarz T,. Regulatory T cells. J Invest Dermatol 2006; 126: 15-24. (Pubitemid 43336089)
18. Werfel T,. The role of leukocytes, keratinocytes, and allergen-specific IgE in the development of atopic dermatitis. J Invest Dermatol 2009; 129: 1878-1891.
19. Renner ED, Rylaarsdam S, Anover-Sombke S, Rack AL, Reichenbach J, Carey JC, et al. Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome. J Allergy Clin Immunol 2008; 122: 181-187. (Pubitemid 351899074)
20. Mizesko MC, Banerjee PP, Monaco-Shawver L, Mace EM, Bernal WE, Sawalle-Belohradsky J, et al. Defective actin accumulation impairs human natural killer cell function in patients with dedicator of cytokinesis 8 deficiency. J Allergy Clin Immunol 2013; 131: 840-848.
21. Grimbacher B, Schaffer AA, Holland SM, Davis J, Gallin JI, Malech HL, et al. Genetic linkage of hyper-IgE syndrome to chromosome 4. Am J Hum Genet 1999; 65: 735-744. (Pubitemid 30468718)
22. Stalder JF, Barbarot S, Wollenberg A, Holm EA, De Raeve L, Seidenari S, et al. Patient-Oriented SCORAD (PO-SCORAD): a new self-assessment scale in atopic dermatitis validated in Europe. Allergy 2011; 66: 1114-1121.
23. den Dunnen JT, Antonarakis SE,. Nomenclature for the description of human sequence variations. Hum Genet 2001; 109: 121-124. (Pubitemid 32743202)
24. Nowak-Wegrzyn A, Sampson HA,. Future therapies for food allergies. J Allergy Clin Immunol 2011; 127: 558-573.
25. Lack G,. Epidemiologic risks for food allergy. J Allergy Clin Immunol 2008; 121: 1331-1336. (Pubitemid 351787358)
26. Santos AF, Lack G,. Food allergy and anaphylaxis in pediatrics: update 2010-2012. Pediatr Allergy Immunol 2012; 23: 698-706.
27. Salt BH, Boguniewicz M, Leung DY,. Severe refractory atopic dermatitis in adults is highly atopic. J Allergy Clin Immunol 2007; 119: 508-509. (Pubitemid 46204818)
28. Kerzel S, Dehne J, Rogosch T, Schaub B, Maier RF, Zemlin M,. Th17 cell frequency in peripheral blood from children with allergic asthma correlates with the level of asthma control. J Pediatr 2012; 161: 1172-1174.
29. Hayashida S, Uchi H, Moroi Y, Furue M,. Decrease in circulating Th17 cells correlates with increased levels of CCL17, IgE and eosinophils in atopic dermatitis. J Dermatol Sci 2011; 61: 180-186.
30. Akdis CA, Akdis M,. Mechanisms and treatment of allergic disease in the big picture of regulatory T cells. J Allergy Clin Immunol 2009; 123: 735-746.
31. Palomares O, Yaman G, Azkur AK, Akkoc T, Akdis M, Akdis CA,. Role of Treg in immune regulation of allergic diseases. Eur J Immunol 2010; 40: 1232-1240.
32. Ochs HD, Oukka M, Torgerson TR,. TH17 cells and regulatory T cells in primary immunodeficiency diseases. J Allergy Clin Immunol 2009; 123: 977-983.
33. Torgerson TR, Ochs HD,. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked: forkhead box protein 3 mutations and lack of regulatory T cells. J Allergy Clin Immunol 2007; 120: 744-750. (Pubitemid 47531861)
34. Shi HZ, Li S, Xie ZF, Qin XJ, Qin X, Zhong XN,. Regulatory CD4+CD25+ T lymphocytes in peripheral blood from patients with atopic asthma. Clin Immunol 2004; 113: 172-178. (Pubitemid 39296850)
35. Bellinghausen I, Klostermann B, Knop J, Saloga J,. Human CD4+CD25+ T cells derived from the majority of atopic donors are able to suppress TH1 and TH2 cytokine production. J Allergy Clin Immunol 2003; 111: 862-868. (Pubitemid 36470261)
36. Vukmanovic-Stejic M, McQuaid A, Birch KE, Reed JR, Macgregor C, Rustin MH, et al. Relative impact of CD4+CD25+ regulatory T cells and tacrolimus on inhibition of T-cell proliferation in patients with atopic dermatitis. Br J Dermatol 2005; 153: 750-757. (Pubitemid 41415901)
37. Grindebacke H, Wing K, Andersson AC, Suri-Payer E, Rak S, Rudin A,. Defective suppression of Th2 cytokines by CD4CD25 regulatory T cells in birch allergics during birch pollen season. Clin Exp Allergy 2004; 34: 1364-1372. (Pubitemid 39233690)
38. Bacchetta R, Gambineri E, Roncarolo MG,. Role of regulatory T cells and FOXP3 in human diseases. J Allergy Clin Immunol 2007; 120: 227-235. (Pubitemid 47102400)
39. Lesiak A, Smolewski P, Sobolewska-Sztychny D, Sysa-Jedrzejowska A, Narbutt J,. The role of T-regulatory cells and Toll-like receptors 2 and 4 in atopic dermatitis. Scand J Immunol 2012; 76: 405-410.
40. Ou LS, Goleva E, Hall C, Leung DY,. T regulatory cells in atopic dermatitis and subversion of their activity by superantigens. J Allergy Clin Immunol 2004; 113: 756-763. (Pubitemid 38530433)
41. Milner JD, Brenchley JM, Laurence A, Freeman AF, Hill BJ, Elias KM, et al. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 2008; 452: 773-776. (Pubitemid 351521078)
42. de Beaucoudrey L, Puel A, Filipe-Santos O, Cobat A, Ghandil P, Chrabieh M, et al. Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J Exp Med 2008; 205: 1543-1550. (Pubitemid 351962017)
43. Siegel AM, Stone KD, Cruse G, Lawrence MG, Olivera A, Jung MY, et al. Diminished allergic disease in patients with STAT3 mutations reveals a role for STAT3 signaling in mast cell degranulation. J Allergy Clin Immunol 2013; 132: 1388-1396.
44. Hill DA, Siracusa MC, Abt MC, Kim BS, Kobuley D, Kubo M, et al. Commensal bacteria-derived signals regulate basophil hematopoiesis and allergic inflammation. Nat Med 2012; 18: 538-546.